Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cho-Ming Loi

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 5, 2013
Which metabolites circulate?Cho-Ming Loi, Dennis A Smith, Deepak Dalvie
Journal of Clinical Pharmacology|July 13, 2016
Physiologically Based Pharmacokinetic Modeling of PalbociclibYanke Yu, Cho-Ming Loi, Justin Hoffman, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 19, 2007
Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humansSusan Hurst, Cho-Ming Loi, Joanne Brodfuehrer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 8, 2017
Application of Physiologically Based Pharmacokinetic Modeling to the Understanding of Bosutinib Pharmacokinetics: Prediction of Drug-Drug and Drug-Disease InteractionsChiho Ono, Poe-Hirr Hsyu, Richat Abbas, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 10, 2018
Application of Physiologically Based Pharmacokinetic Modeling in Understanding Bosutinib Drug-Drug Interactions: Importance of Intestinal P-GlycoproteinShinji Yamazaki, Cho-Ming Loi, Emi Kimoto, et al.
Cancer Chemotherapy and Pharmacology|September 1, 2006
Pharmacodynamic and toxicokinetic evaluation of the novel MEK inhibitor, PD0325901, in the rat following oral and intravenous administrationAlan P Brown, Tage C G Carlson, Cho-Ming Loi, et al.
Drug Metabolism Letters|April 10, 2009
Application of in-line liquid chromatography-accurate radioisotope counting-mass spectrometry (LC-ARC-MS) to evaluate metabolic profile of [3H]-mefenamic acid in rat plasmaWing Lam, Cho-Ming Loi, James Atherton, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 31, 2009
Cross-species comparison of the metabolism and excretion of zoniporide: contribution of aldehyde oxidase to interspecies differencesDeepak Dalvie, Chenghong Zhang, Weichao Chen, et al.
Cancer Chemotherapy and Pharmacology|June 14, 2013
A phase I, open-label, mass balance study of [(14)C] dacomitinib (PF-00299804) in healthy male volunteersCarlo L Bello, Evan Smith, Ana Ruiz-Garcia, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 6, 2005
Roles of exercise and pharmacokinetics in cerivastatin-induced skeletal muscle toxicityJennifer L Seachrist, Cho-Ming Loi, Mark G Evans, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 5, 2013
Which metabolites circulate?Cho-Ming Loi, Dennis A Smith, Deepak Dalvie
Journal of Clinical Pharmacology|July 13, 2016
Physiologically Based Pharmacokinetic Modeling of PalbociclibYanke Yu, Cho-Ming Loi, Justin Hoffman, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 19, 2007
Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humansSusan Hurst, Cho-Ming Loi, Joanne Brodfuehrer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 8, 2017
Application of Physiologically Based Pharmacokinetic Modeling to the Understanding of Bosutinib Pharmacokinetics: Prediction of Drug-Drug and Drug-Disease InteractionsChiho Ono, Poe-Hirr Hsyu, Richat Abbas, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 10, 2018
Application of Physiologically Based Pharmacokinetic Modeling in Understanding Bosutinib Drug-Drug Interactions: Importance of Intestinal P-GlycoproteinShinji Yamazaki, Cho-Ming Loi, Emi Kimoto, et al.
Cancer Chemotherapy and Pharmacology|September 1, 2006
Pharmacodynamic and toxicokinetic evaluation of the novel MEK inhibitor, PD0325901, in the rat following oral and intravenous administrationAlan P Brown, Tage C G Carlson, Cho-Ming Loi, et al.
Drug Metabolism Letters|April 10, 2009
Application of in-line liquid chromatography-accurate radioisotope counting-mass spectrometry (LC-ARC-MS) to evaluate metabolic profile of [3H]-mefenamic acid in rat plasmaWing Lam, Cho-Ming Loi, James Atherton, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 31, 2009
Cross-species comparison of the metabolism and excretion of zoniporide: contribution of aldehyde oxidase to interspecies differencesDeepak Dalvie, Chenghong Zhang, Weichao Chen, et al.
Cancer Chemotherapy and Pharmacology|June 14, 2013
A phase I, open-label, mass balance study of [(14)C] dacomitinib (PF-00299804) in healthy male volunteersCarlo L Bello, Evan Smith, Ana Ruiz-Garcia, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 6, 2005
Roles of exercise and pharmacokinetics in cerivastatin-induced skeletal muscle toxicityJennifer L Seachrist, Cho-Ming Loi, Mark G Evans, et al.
Pageof 2